CORC  > 复旦大学上海医学院
Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study
Guan, Wenlong; Sun, Feng; Li, Yang; Chen, Yu; Jiang, Xiangao; Wang, Xiaomeng; Ren, Pengfei; Li, Junlian; Shi, Jichan; He, Guiqing
刊名EUROPEAN RESPIRATORY JOURNAL
2019
卷号53期号:3
ISSN号0903-1936
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3595173
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Guan, Wenlong,Sun, Feng,Li, Yang,et al. Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study[J]. EUROPEAN RESPIRATORY JOURNAL,2019,53(3).
APA Guan, Wenlong.,Sun, Feng.,Li, Yang.,Chen, Yu.,Jiang, Xiangao.,...&Zhang, Wenhong.(2019).Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study.EUROPEAN RESPIRATORY JOURNAL,53(3).
MLA Guan, Wenlong,et al."Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study".EUROPEAN RESPIRATORY JOURNAL 53.3(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace